News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
JFL Capital Management, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/19/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/24/2019 |
SC 13D/A
| JFL Capital Management, LLC reports a 9.4% stake in Merrimack Pharmaceuticals, Inc. |
| 09/24/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 08/22/2019 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 08/19/2019 |
PRRN14A
| Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise: |
| 08/13/2019 |
PRRN14A
| Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise: |
| 08/06/2019 |
PREC14A
| Form PREC14A - Preliminary proxy statements, contested solicitations: |
| 07/24/2019 |
SC 13D/A
| JFL Capital Management, LLC reports a 9.4% stake in Merrimack Pharmaceuticals, Inc. |
| 07/02/2019 |
4
| JFL Capital Management, LLC (10% Owner) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Bought 9,662 shares
@ $5.945, valued at
$57.4k
Bought 13,902 shares
@ $5.945, valued at
$82.6k
Bought 3,934 shares
@ $6.0029, valued at
$23.6k
Bought 5,659 shares
@ $6.0029, valued at
$34k
Bought 7,024 shares
@ $5.848, valued at
$41.1k
Bought 10,107 shares
@ $5.848, valued at
$59.1k
|
|
| 05/31/2019 |
SC 13G
| JFL Capital Management, LLC reports a 6% stake in Novelion Therapeutics Inc. |
| 04/17/2019 |
SC 13D/A
| JFL Capital Management, LLC reports a 9.3% stake in Merrimack Pharmaceuticals, Inc. |
| 04/09/2019 |
4
| JFL Capital Management, LLC (10% Owner) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Bought 26,288 shares
@ $5.952, valued at
$156.5k
Bought 6,484 shares
@ $5.7264, valued at
$37.1k
Bought 4,506 shares
@ $5.7264, valued at
$25.8k
|
|
| 03/20/2019 |
3
| JFL Capital Management, LLC (10% Owner) has filed a Form 3 on MERRIMACK PHARMACEUTICALS INC |
| 03/14/2019 |
SC 13D/A
| JFL Capital Management, LLC reports a 8.7% stake in Merrimack Pharmaceuticals, Inc. |
| 02/11/2019 |
SC 13G/A
| JFL Capital Management, LLC reports a 7% stake in Catalyst Biosciences, Inc. |
| 01/25/2019 |
SC 13G
| JFL Capital Management, LLC reports a 8.2% stake in Sunesis Pharmaceuticals, Inc. |
| 12/19/2018 |
SC 13D/A
| JFL Capital Management, LLC reports a 8.5% stake in Merrimack Pharmaceuticals, Inc. |
| 11/02/2018 |
SC 13D
| JFL Capital Management, LLC reports a 7.1% stake in Merrimack Pharmaceuticals, Inc. |
| 08/02/2018 |
SC 13G
| JFL Capital Management, LLC reports a 5.4% stake in Catalyst Biosciences, Inc. |
| 07/27/2018 |
3/A
| JFL Capital Management, LLC (5% owner) has filed a Form 3/A on CATALYST BIOSCIENCES, INC. |
| 07/27/2018 |
3
| JFL Capital Management, LLC (5% owner) has filed a Form 3 on CATALYST BIOSCIENCES, INC. |
| 10/19/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|